Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 75-91

  De la Torre, J C ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; GLUCOSE; NEUROTRANSMITTER;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN METABOLISM; BRAIN NERVE CELL; CONFERENCE PAPER; ELECTRON MICROSCOPY; HUMAN; MICROSCOPY; NEUROFIBRILLARY TANGLE; SENILE PLAQUE; VASCULAR DISEASE;

EID: 0030668579     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48462.x     Document Type: Conference Paper

References (153)

1. ALEXIANU, M. & B. TUDORACHE 1994. Structural modifications of intracerebral small blood vessels in various types of dementia. Rom. J. Neurol. Psychiat. 32: 141-152.
2. KALARIA, R. N. & P. J. HEDERA. 1995. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6: 477-480.
3. FISHER, V. W., A. SIDDIGI & Y. YUSUFALY. 1990. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropath. 79: 672-679.
4. DELACOURTE, A., A. DEFOSSEZ, P. PERSUY & M. C. PEERO. 1987. Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Arch. 411: 199-204.
5. HASSLER, O. 1967. Arterial deformities in senile brains. Acta Neuropath. 8: 219-229.
6. RAVENS, J. R. 1978. Vascular changes in the human senile brain. In Pathology of cerebrospinal microcirculation. J. Cervos-Navarro, Ed.: 487-501. Raven Press. New York.
7. BESKOW, J., O. HASSLER & J. O. OTTOSON. 1971. Cerebral arterial deformities in relation to senile deterioration. Acta Psychiatr. Scand. 221: 111-119.
8. HIGUCHI, Y., T. MIYAKAWA, A. SHIMOJI & S. KATSURAGI. 1987. Ultrastructural changes in blood vessels in the cerebral cortex in Alzheimer's disease. Jpn. J. Psychiatry Neurol. 41: 283-290.
9. KIDD, M. 1964. Alzheimer's disease: An electron microscopic study. Brain 87: 307-320.
10. MIYAKAWA, T. & R. KURAMOTO. 1989. Ultrastructural study of senile plaques and microvessels in the brain with Alzheimer's disease and Down's syndrome. Ann. Med. 21: 99-102.
11. MIYAKAWA, T. & Y. UEHARA. 1979. Observation of amyloid angiopathy and senile plaque under a scanning electron microscope. Acta Neuropath. 48: 153-156.
12. SCHEIBEL, A. B., T. DUONG & R. JACOBS. 1989. Alzheimer's disease as a capillary dementia. Ann. Med. 22: 103-107.
13. AMARAL, D. G. & R. INSAUSTI. 1990. Hippocampal formation. In The human nervous system. G. Paxinos, Ed.: 711-755. Academic Press. New York.
14. PERLMUTTER, L. S., J. ATHANIKAR, C. ZAROW & H. CHUI. 1988. Basement membrane pathology in dementia. Abstr. Soc. Neurosci. 14: 639.
15. KIMURA, T., T. HASHIMURA & T. MIYAKAWA. 1991. Observations of microvessels in the brain of Alzheimer's disease by the scanning electron microscopy. Jpn. J. Psychiat. Neurol. 45: 671-676.
16. PERLMUTTER, L. S., M. A. MYERS & E. BARRON. 1994. Vascular basement membrane components and the lesions of Alzheimer's disease. Micros. Res. Tech. 28:204-215.
17. MANCARDI, G. L., F. PERDELLI, A. LEONARDI & O. BUGIANI. 1980. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol. 49: 79-83
18. YAMASHITA, K., T. MIYAKAWA & S. KATSURAGI. 1991. Vascular changes in the brains of Alzheimer's disease. Jpn. J. Psychiat. Neurol. 45: 79-84.
19. SCHEIBEL, A. B., R. DUONG & O. TOMYASU. 1986. Microvascular changes in Alzheimer's disease. In The Biological Substrates of Alzheimer's Disease. A. B. Scheibel, Ed.: 77-192. Academic Press. New York.
20. MIYAKAWA, T., S. KATSURAGI, K. WATANABE, A. SHIMOJI & Y. IKEUCHI. 1986. Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuro pathol. 70: 202-208.
21. MIYAKAWA, T. & Y. UEHARA. 1979. Observation of amyloid angiopathy and senile plaque under a scanning electron microscope. Acta Neuropath. 48: 153-156.
22. MIYAKAWA, T. & R. KURAMOTO. 1989. Ultrastructural study of senile plaques and microvessels in the brain with Alzheimer's disease and Down's syndrome. Ann. Med. 21: 99-102.
23. HIGUCHI, Y., T. MIYAKAWA, A. SHIMOJI & S. KATSURAJI. 1987. Ultrastructural changes of blood vessels in the cerebral cortex in Alzheimer's disease. Jpn. J. Psychiat. Neurol. 41: 283-290.
24. MIYAKAWA, T., A. SHIMOJI, R. KURAMOTO & Y. HIGUCHI. 1982. The relationship between senile plaques and cerebral vessels in Alzheimer's disease and senile dementia. Virchows Archiv. B 40: 121-129.
25. MANN, D. M. A., M. PURKISS, R. E. BONSHEK, D. JONES, M. BROWN & R. W. STODDART. 1991. Lectin histochemistry of cerebral microvessels in ageing, Alzheimer's disease and Down's syndrome. Neurobiol. Aging 13: 137-143.
26. KALARIA, R. N. & P. HEDERA. 1995. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6: 477-480.
27. BUÉE, L., P. R. HOF, D. BOURAS, A. DELACOURTE, D. PERL, J. H. MORRISON & H. M. FILLIT. 1994. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related demented disorders. Acta Neuropathol. 87:469-480.
28. VINTERS, H. V., D. L. SECOR, S. L. READ, J. FRAZEC, U. TOMIYASU, T. M. STANKY, J. FERREIRO & M. A. AKERS. 1994. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastr. Pathol. 18: 333-348.
29. ZLOCOVIC, B. V., J. GHISO, J. MACKIC, M. H. WEISS & B. FRANGIONE. 1993. Bloodbrain barrier transport of circulating Alzheimer's amyloid beta. Biochem. Biophys. Res. Commun. 30: 1034-1040.
30. MOODY, D. M., W. P. SANTAMOR & M. A. BELL. 1991. Does tortuosity in cerebral arterioles impair low-regulation in hypertensives and elderly normotensives? A hypotheses and computer model. Clin. Neurosurg. 37: 371-387.
31. DE LA TORRE, J. C. & T. MUSSIAND. 1993. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res. 15: 146-153.
32. DE LA TORRE, J. C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Behav. Rev. 18: 397-401.
33. GAEHTGENS, P. & P. MARX. 1987. Hemorheological aspects of the pathophysiology of cerebral ischemia. J. Cereb. Blood Flow Metab. 7: 259-265.
34. FUNG, Y. C. 1984. Biodynamics Circulation. Springer-Verlag. New York.
35. NAIR, P. K., J. HELLUMS & J. OLSON. 1989. Prediction of oxygen transport rates in blood flowing in large capillaries. Microvasc. Res. 36: 269-285.
36. DINTENFASS, L. 1980. Hemorheology and the microcirculation: Role of the inversion phenomenon. In Progress in Mirocirculation Research. D. Garlick, Ed.: 100-140. University of South Wales. Sydney.
37. FUNG, Y. C. 1981. Biomechanics. Springer-Verlag. New York.
38. ERECINSKA, M. & I. SILVER. 1989. ATP and brain function. J. Cereb. Blood Flow Metab. 9: 2-19.
39. +-dependent p-nitrophenylphosphatase (transport ATPase) in the mouse central and peripheral nervous systems. Brain Res. 241: 225-234.
40. BACHELARD, H. S. 1975. Energy utilized by neurotransmitters. In Brain Work: The Coupling of Function, Metabolism, and Blood Flow in the Brain. A. Benson Symposium VIII, D. H. Ingvar & N. A. Lassen, Eds.: 799-781. Academic Press. New York.
41. HUGANIR, R. L. & P. GREENOARD. 1990. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5: 555-567.
42. KADEKARO, M., A. M. CRANE & L. SOKOLOFF. 1985. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc. Natl. Acad. Sci. USA 82: 6010-6013.
43. EHRLICH, Y. H., T. B. DAVIS, E. BOCK, E. KORNECKI & R. H. LENOX. 1986. Ectoprotein kinase activity on the external surface of neural cells. Nature 320: 67-70.
44. GREENGARD, P. 1978. Phosphorylated proteins as physiological effectors. Science 199: 146-152.
45. PARDRIDGE, W. M. 1984. Transport of nutrient and hormones through the blood-brain barrier. Fed. Proc. 43: 201-204.
46. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40: 711-714.
47. HOYER, S. 1991. Abnormalities of glucose metabolism in Alzheimer's disease. Ann. N. Y. Acad. Sci. 640: 53-58.
48. HOYER, S. 1991. Brain energy metabolism and its significance for Alzheimer's disease. In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. K. Iqbal, D. R. C. McLachlan, B. Winblad & H. M. Wisniewski, Eds.: 53-57. Wiley & Sons. New York.
49. HOYER, S. 1986 Senile dementia and Alzheimer's disease, brain blood flow and metabolism. Prog. Neuro-psychopharmacol. Biol. Psychiatry 10: 447-478.
50. FRIEDLAND, R. P., T. BUDINGER, E. Koss & B. OBER. 1985. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett. 53: 235-240.
51. FRACKOWIAK, R. S., C. POZZILLI, J. MARSHALL, G. LENZI & T. JONES. 1981. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104: 753-778.
52. MARCUS, D. L., M. DE LEON, J. GOLDMAN, J. LOGAN, D. CHRISTMAN, A. WOLF, J. FOWLER, K. HUNTER, J. TSAI, J. PEARSON & M. L. FREEDMAN. 1989. Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann. Neurol. 26: 91-94.
53. KUHL, C. E., E. METTER, W. H. RIEGE & R. HAWKINS. 1985. Patterns of cerebral glucose utilization in dementia. In The metabolism of the Human Brain Studies with Positron Emission Tomography. T. Grietz, Ed.: 419-431. Raven Press. New York.
54. HAXBY, J. V., C. GRADY, E. KOSS, B. HORWITX, M. SCHAPIRO, R. P. FRIEDLAND & S. I. RAPOPORT. 1988. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 38: 1853-1863.
55. DUARA, R., C. GRADY & J. HAXBY. 1986. Positron emission tomography in Alzheimer's disease. Neurology 36: 879-887.
56. MEIER-RUGE, W., C. BERTONI-FREDDARI & P. IWANGOFF. 1994. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 40: 246-252.
57. DASTUR, D. K. 1985. Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J. Cereb. Blood Flow Metab. 5: 1-9.
58. 15O and positron emission tomography: Theory, procedure, and normal values. J. Computer Assisted Tomog. 4: 727-736.
59. PANTANO, P., J. C. BARON, P. LEBRUN-GRANDIE, N. DUGUESNOY, M. BOUSSEN & G. COMAR. 1984. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 15: 635-641.
60. MELAMED, E., S. LAVY, S. BENTIN, G. COOPER & Y. RINOT. 1980. Reduction in regional cerebral blood flow during normal aging in man. Stroke 11: 331-334.
61. MEYER, J. S., Y. TERAYAMA & S. TAKASHIMA. 1993. Cerebral circulation in the elderly. Cerebrovasc. Brain Metab. Rev. 5: 122-146.
62. BARON, J. C. & G. MARCHAL. 1992. Vieillessement cérébral et cardiovasulaire et metabolisme énergétique, cérébral. Presse Med. 21: 1231-1237.
63. LASSEN, N. A. & D. H. INGVAR. 1980. Blood flow studies in the aging normal brain and in senile dementia. In Aging of the Brain and Dementia. L. Amaducci, A. N. Davison & P. Antuone, Eds.: 91-98. Raven Press. New York.
64. 133Xenon inhalation. Stroke 6: 245-256.
65. HOYER, S., R. NITSCH & K. OESTERREICH. 1991. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases. J. Neural Transm. (P-D Sect) 3: 1-14.
66. HOYER, S. 1994. Age as risk factor for sporadic dementia of the Alzheimer type? Ann N. Y. Acad. Sci. 719: 248-256.
67. PALMER, A. M. & S. T. DEKOSKY. 1993. Monoamine neurons in aging and Alzheimer's disease. J. Neural Transm. 91: 135-159.
68. SOININEN, H., K. REINIKAINEN, J. PARTANEN, E. MERVAALA, L. PALJARVI, E. HELKALA & P. RIEKINNEN. 1992. Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus of patients with Alzheimer's disease. Neurosci. Lett. 137: 5-8.
69. NAZARALI, A. J. & G. P. REYNOLDS. 1992. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: A postmortem study. Cell. Mol. Neurobiol. 12: 581-587.
70. HOYER, S. 1996. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta. Neurol. Scand. Suppl. 195: 18-24.
71. HOYER, S. 1988. Glucose metabolism as the site of the primary abnormality in earlyonset dementia of the Alzheimer type? J. Neurol. 235:143-148.
72. MEIER-RUGE, W. & C. BERTONI-FREDDARI. 1996. The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease. Rev. Neurosci. 7: 1-19.
73. BLASS, J. P. & G. E. GIBSON. 1991. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris) 147: 513-525.
74. TUCEK, S. 1985. Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44: 11-24.
75. CUMMINGS, J. L. & D. F. BENSON. 1987. The role of the nucleus basalis of Meynert in dementia: Review and reconsideration. Alz. Dis. Assoc. Dis. 1: 128-145.
76. SIMPSON, I. A., K. R. CHUNDU, T. DAVIES-HILL, W. HONER & P. DAVIES. 1994. Decreased concentrations of GLUT1 and GLUTS glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35: 546-551.
77. KALARIA, R. N. & S. E. HARIK. 1989. Reduced glucose transporter at the blood brain barrier and in the cerebral cortex in Alzheimer's disease. J. Neurochem. 53: 1083-1088.
78. MARCUS, D. L., J. J. DE LEON, J. GOLDMAN, J. LOGAN, D. CHRISTMAN A. WOLF, J. FOWLER, K. HUNTER & J. TSAI. 1990. Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann. Neurol. 27: 691-693.
79. 2--ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 112: 338-342.
80. CLARKE, D. D. & L. SOKOLOFF. 1994. Circulation and energy metabolism of the brain. In Basic Neurochemistry. G. J. Siegel, B. W. Agranoff, R. W. Albers & P. B. Molinoff, Eds.: 645-680. Raven Press. New York.
81. PERRY, E. K., R. H. PERRY, B. E. TOMLINSON, G. BLESSED & P. GIBSON. 1980. Coenzyme A-acetylating enzymes in Alzheimer's disease: Possible cholinergic compartment of pyruvate dehydrogenase. Neurosci. Lett. 18: 105-110.
82. NOHL, H. 1986. Oxygen radical release in mitochondria: influence of age. In Free Radicals, Aging, and Degenerative Diseases. J. E. Johnson, Jr., R. Walford, D. Harman & J. Miquel, Eds.: 77-97. Alan R. Liss. New York.
83. BERTONI-FREDDARI, C., P. FATTORETTI, T. CASOLI, W. MEIER-RUGE & J. ULRICH. 1991. Reactive capacities of the central nervous system in physiological aging and senile dementia of the Alzheimer type. Ann. N. Y. Acad. Sci. 621: 98-103.
84. PLASCHKE, K. & S. HOYER. 1993. Action of the diabetogenic drug steptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int. J. Dev. Neurosci. 11: 477-483.
85. NITSCH, T. & S. HOYER. 1991. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci. Lett. 128: 199-202.
86. DE LA TORRE, J. C. 1992. Does brain microvessel pathology provoke Alzheimer's disease? Soc. Neurosci. Abstr. 18: 565.
87. DE LA TORRE, J. C. 1997. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 43: 26-43.
88. SELKOE, D. J., M. D. POLISNY, C. JOACHIM, E. A. VICKERS, G. LEE, L. C. FRITZ & T. OLTERSDORF. 1988. Beta-amyloid precursor protein of Alzheimer's disease occurs at 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. USA 85: 7341-7345.
89. SISODIA, S. S., E. H. KOO, K. BEYREUTHER, U. UNTERBECK & D. L. PRICE. 1990. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495.
90. ABE, K., R. E. TANZI & K. KOGURE. 1991. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125: 172-174.
91. BARGER, S. W., V. L. SMITH-SWINTOSKY, R. E. RYDEI. & M. P. MATTSON. 1993. β-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease. Ann. N. Y. Acad. Sci. USA 695: 158-164.
92. GLENNER, G. G. & C. W. WONG. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
93. LEHNINGER, A. L., D. L. NELSON & M. M. COX. 1993. Principles of Biochemistry.: 475-477. Worth. New York.
94. WISNIEWSKI, H. M., H. K. NARANG & R. D. TERRY. 1976. Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 27: 173-181.
95. LEE, V. M. Y., B. BALIN, L. OTVOS & J. Q. TROJANOWSKI. 1991. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251: 675-678.
96. MATTSON, M. P., M. G. ENGLE & B. RYCHLIK. 1991. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol. Chem. Neuropathol. 15: 117-142.
97. CHENG, B. & M. P. MATTSON. 1992. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampus neurons. Prevention by NGF:bFGF. Exp. Neurol. 117: 114-123.
98. NUKINA, N., K. S. KOSIK & D. SELKOE. 1988. The monoclonal antibody, ALZ-50, recognizes tau proteins in Alzheimer's disease brains. Neurosci. Lett. 87: 240-246.
99. RODER, H. M. & V. M. INGRAM. 1991. Two novel kinases phosphorylate tau and the KDP site of heavy neurofilament subunits in high stoichiometric ratios. J. Neurosci. 11: 3325-3343.
100. KATZMAN, R. 1986. Alzheimer's disease. New Engl. J. Med. 314: 964-973.
101. RASMUSSON, D. X., J. BRANDT, D. B. MARTIN & M. FOLSTEIN. 1995. Head injury as a risk factor in Alzheimer's disease. Brain Injury 9: 213-219.
102. GRAHAM, D. I., S. M. GENTLEMAN, A. LYNCH & G. W. ROBERTS. 1995. Distribution of beta-amyloid protein in the brain following severe brain injury. Neuropathol. Appl. Neurobiol. 21: 27-34.
103. LEIBSON, C., W. ROCCA, V. HANSON R. CHA, E. KOKMEN, P. O'BRIEN & P. PALUMBO. The risk of dementia among persons with diabetes mellitus. Ann. N. Y. Acad. Sci. This volume.
104. LANDIN, K., K. BLENNOW, A. WALLIN & C. G. GOTTFRIES. 1993. Low blood pressure and blood glucose levels in Alzheimer's disease: Evidence for a hypometabolic disorder? J. Int. Med. 233: 257-263.
105. SKOOG, I., B. LERNFELT, B. PALMERTZ, L. A. ANDREASSON, L. NILSSON, G. PERSSON, A. ODEN & A. SVANBORG. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
106. JENDROSKA, K., W. POEWE, S. E. DANIEL, J. PLUESS, H. IWERSSEN-SCHMIDT, J. PAULSEN, S. BARTHEL, L. SCHELOSKY, J. CERVOS-NAVARRO & S. DEARMOND. 1995. Ischemic stress induces deposition of amyloid β immunoreactivity in human brain. Acta Neuropathol. 90: 461-466.
107. SPARKS, D. L., J. C. HUNSAKER, S. W. SCHEFF, R. J. KRYSCIO, J. HENSON & W. R. MARKESBERG. 1990. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 11: 601-607.
108. 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 44: 2420-2421.
109. DARTIQUES, J. F., M. GAGNON, P. MICHEL & L. LETTERNEUS. 1991. The Paquid research program on the epidemiology of dementia. Methods and initial research. Rev. Neurol. 147: 225-230.
110. BARCLAY, L., A. ZEMCOR & W. REICHERT. 1985. Cerebral blood flow decrements in chronic head injury syndrome. Biol. Psychiat. 20: 146-157.
111. TERAYAMA, S., J. S. MEYER & J. KAWAMURA. 1991. Cognitive recovery correlates with long-term increases of cerebral perfusion after head injury. Surg. Neurol. 36: 335-342.
112. ROBERTS, G. W., S. M. GENTLEMAN, A. LYNCH, L. MURRAY, M. LANDON & D. I. GRAHAM. 1994. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 57: 419-425.
113. PROHOVNIK, I., R. MAYEUX, H. A. SACKHEIM, G. SMITH, Y. STERN & P. O. ALDERSON. 1988. Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 38: 931-937.
114. TRESCH, D., M. FOLSTEIN, P. ROBINS & W. HAZZARD. 1985. Prevalence and significance of cardiovascular disease and hypertension in elderly patients with dementia and depression. J. Am. Geriatr. Soc. 33: 530-537.
115. REICH, P., Q. REGESTEIN, B. MURAWSKI, R. DESILVA & B. LOWN. 1983. Unrecognized organic mental disorders in survivors of cardiac arrest. Am. J. Psychiatry 140: 1194-1197.
116. MOHR, J. 1979. Neurological complications of cardiac valvular disease and cardiac surgery including systemic hypotension. In Neurological Manifestations of Systemic Diseases. Handbook of Clinical Neurology. P. J. Vinken & G. W. Bruyn, Eds. Vol. 38, part 1: 143-171. North Holland. New York.
117. 123 I-IMP with SPECT. Nuclear Med. Commun. 15: 455-460.
118. TALLROTH, G., E. RYDING & C. D. AGARDTH. 1993. The influence of hypoglycemia on regional cerebral blood flow and cerebral volume in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 530-535.
119. DESMOND, D. W., T. K. TATEMICHI & Y. STERN. 1993. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch. Neurol. 50: 162-166.
120. SPARKS, D. L., S. W. SCHEFF, H. LIU, T. M. LANDERS, C. COYNE & J. HUNSAKER. 1995. Increased incidence of neurofibrillary tangles in non-demented individuals with hypertension. J. Neurol. Sci. 131: 162-169.
121. CELSIS, P., A. AGNIEL, M. PEUL, A. RASCOL & J. VERGNES. 1987. Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J. Neurol. Neurosurg. 50: 1602-1612.
122. GUO, Z., M. VIITANEN, L. FRAGLIONI & B. WINBLAD. 1996. Low blood pressure and dementia in elderly people. Brit. Med. J. 312: 805-808.
123. BURKE, W. J., P. CORONADO, C. SCHMITT, K. GILLESPIE & H. CHUNG. 1994. Blood pressure regulation in Alzheimer's disease. J. Auton. Neurol. Syst. 48: 65-71.
124. CORDER, E. H., A. M. SANDERS, W. J. STRITTMATTER, D. SCHMECHEL, P. C. GASKELL, G. SMALL, A. D. ROSES, J. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261: 921-923.
125. DAVIGNON, J., R. E. GREGG & C. F. SING. 1988. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8: 1-21.
126. BOTET, J. P., M. SHNTÍ, X. NOGUÉS, J. RUBIÉS-PRAT, J. ROQUER, L. D' OLHABERRIAGUE & J. OLIVE. 1992. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 23: 1556-1562.
127. BATES, H. M. 1989. Apolipoproteins and coronary heart disease risk assessment. Diagnostics Clin. Testing 27: 52-53.
128. LEHTINEN, S., T. LEHTIMAKI, T. SISTO, J. SALENIUS, M. NIKKILA, H. JOKELA, T. KOIVULA, F. EBERLING & C. EHNHOLM. 1995. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 114: 83-91.
129. 4 allele frequency, ischemic cerebrovascular disease and Alzheimer's disease. Stroke 24: 1416-1417.
130. 4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 25: 1703.
131. NOGUCHI, S., K. MUTAKAMI & N. YAMADA. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet 342: 737.
132. SHIMANO, H., S. ISHIBASHI & T. MURASE. 1989. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 79: 257-260.
133. SUMMERS, W. K., L. V. MAJORSKI, G. MARSH, K. TACHIKI & A. KLING. 1986. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315: 1241-1242.
134. TUNE, L., J. BRANDT, J. FROST, G. HARRIS, H. MAYBERG & C. STEELE. 1991. Physostigmine in Alzheimer's disease: Effects on cognitive functioning, cerebral glucose metabolism analyzed by PET and cerebral blood flow analyzed by SPECT. Acta Psychiatr. Scand. Suppl. 366: 61-65.
135. BECKER, R. E. & E. GIACOBINI. 1988. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer's type: Clinical, pharmacological and therapeutic aspects. Drug Dev. Res. 12: 163-195.
136. KUMAR, V. & M. CALACHE. 1991. Treatment of Alzheimer's disease with cholinergic drugs. Int. J. Clin. Pharmacol. Ther. Toxicol. 29: 23-37.
137. CAAMANO, J., M. J. GOMEZ, A. FRANCO-MASIDE & R. CACABELOS. 1994. Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer's disease. Meth. Find. Exp. Clin. Pharmacol. 16: 211-218.
138. CACABELOS, R., J. CAAMANO, L. FERNANDEZ-NOVOA, A. FRANCO-MASIDE & X. A. ALVAREX. 1996. Therapeutic effects of CDP-choline in Alzheimer's disease. Ann. N. Y. Acad. Sci. 777: 399-403.
139. DE LA TORRE, J. C. 1991. Synergic activity of combined prostacyclin: Dimethyl sulfoxide in experimental brain ischemia. Can. J. Physiol. Pharmacol. 69: 191-198.
140. MULLAN, S., J. JAFAR, K. HANLON & F. D. BROWN. 1980. Dimethyl sulfoxide in the management of postoperative hemiplegia. In Cerebral Arterial Spasm.: 646-653. Williams & Wilkins. Baltimore, MD.
141. BROWN, F. D., L. JOHNS & S. MULLAN. 1983. Dimethyl sulfoxide therapy following penetrating brain injury. Ann. N. Y. Acad. Sci. 411: 245-252.
142. GROPPA, S. A. 1994. New possibilities in the treatment of patients with Alzheimer's disease. Neurobiol. Aging 15: S101.
143. MCGEER, P. L., E. MCGEER, J. ROGERS & J. SIBLEY. 1990. Anti-inflammatory drugs and Alzheimer's disease. Lancet 335: 1037.
144. RICH, J. B., D. X. RASMUSSON, M. FOLSTEIN, K. CARSON, C. KAWAS & J. BRANDT. 1995. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 51-55.
145. BREITNER, J. C. S., M. GAU, K. A. WELSH, B. PLASSMAN, W. MCDONALD, M. HELMS & J. ANTHONY. 1994. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 44: 227-232.
146. SMITH, W. L. & D. L. DEWITT. 1995. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to non-steroidal antiinflammatory drugs. Sem. Nephrol. 15: 179-194.
147. CHEMTOB, S., K. BEHARRY, T. BARNA, B. R. VARMA & J. V. ARANDA. 1991. Differences in the effects of newborn piglet of various non-steroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Fed. Res. 30: 106-111.
148. OHKURA, T., K. ISSE, K. AKAZAWA, M. HAMAMOTO, Y. YAOI & N. HAGINO. 1994. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine J. 41: 361-371.
149. BIRGE, S. J. 1996. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J. Amer. Geriatr. Soc. 44: 865-870.
150. SCHNEIDER, L. S., M. FARLOW, V. W. HENDERSON & J. POGODA. 1996. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 46: 1580-1584.
151. HARKINS, S. W., J. R. TAYLOR, V. MATTAY & W. REGELSON. Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering. Ann. N. Y. Acad. Sci. This volume.
152. GOLDSMITH, H. S. 1996. Omental transposition for Alzheimer's disease. Neurol. Res. 18: 103-108.
153. DE LA TORRE, J. C., N. NELSON & R. J. SUTHERLAND. 1996. Combined fructose 1,6-diphosphate-diruethyl sulfoxide treatment reverses chronic memory deficits in brain ischemic rats. In Neurochemistry. A. W. Teelken & J. Korf, Eds. Plenum Press. New York. In press.